Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06152185 · ClinicalTrials.gov registry record · NA

Mindfulness App Training for Cardiovascular Health

A NA study of Cardiovascular Diseases and Mindfulness, sponsored by University of Pittsburgh.

Active
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT06152185: Active NA study of Cardiovascular Diseases and Mindfulness, sponsored by University of Pittsburgh.

NCT06152185 is a NA study of Cardiovascular Diseases and Mindfulness that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 106 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06152185, a NA study of Cardiovascular Diseases and Mindfulness, is active but no longer recruiting, sponsored by University of Pittsburgh.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the feasibility and effects of a smartphone-based mindfulness training program vs. usual care in a sample of stressed midlife and older adults at risk for cardiovascular disease. 105 participants will be randomly assigned to complete a four-week mindfulness training intervention, which involves 28 audio-guided lessons and practice prompts delivered 3x daily, or to continue with their regular routines. Data will be collected at baseline, post-intervention, and three-month follow-up. The study will involve seven laboratory visits, which will include assessments and training on daily life monitoring and intervention procedures. Data assessing subjective and physiological stress reactivity in daily life will be collected for 3 days at pre-intervention, post-intervention, and 3-month follow-up. Passive sensor data will be continuously collected from participants' smartphones and wearable devices to develop models that predict daily life stress. Data will be used to evaluate feasibility of the intervention and assessments in a sample at risk for cardiovascular disease and to test effects of mindfulness training on subjective and physiological stress reactivity.

Primary Outcome

Task strain assessed as the proportion of hourly observations during each ambulatory monitoring period that are assigned ratings above the sample median on a 3-item Task Demand scale and below the sample median on a 2-item Decision Latitude scale, with higher scores indicating higher task strain

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Mindfulness Training

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2024-02-06
Est. Completion 2026-06-30
Phase NA
University of Pittsburgh

1,238 total trials

What the registry record for NCT06152185 still lists

NCT06152185 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT06152185 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06152185 about?

NCT06152185 is a clinical study titled "Mindfulness App Training for Cardiovascular Health". This study will investigate the feasibility and effects of a smartphone-based mindfulness training program vs. usual care in a sample of stressed midlife and older adults at risk for cardiovascular disease. 105 participants will be randomly assigned to complete a four-week mindfulness training inter...

What is the current status of trial NCT06152185?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2024-02-06. Estimated completion is 2026-06-30.

What conditions does trial NCT06152185 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Mindfulness.

What interventions are being tested in trial NCT06152185?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Mindfulness Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06152185?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06152185 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06152185's enrollment target sits among peer trials

106 191st of 300 higher than 110 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06152185, the US trial registry maintained by the National Library of Medicine. NCT06152185 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.